Search Results - "Gruys, M E"
-
1
Constitutive expression of functional CD40 on mouse renal cancer cells: Induction of Fas and Fas-mediated killing by CD40L
Published in Cellular Immunology (01-06-2005)“…CD40, a member of the TNF receptor superfamily, is expressed on B cells, dendritic cells, and some tumor cells, including melanoma and bladder carcinoma. In…”
Get full text
Journal Article -
2
Complete Regression of Established Spontaneous Mammary Carcinoma and the Therapeutic Prevention of Genetically Programmed Neoplastic Transition by IL-12/Pulse IL-2: Induction of Local T Cell Infiltration, Fas/Fas Ligand Gene Expression, and Mammary Epithelial Apoptosis
Published in The Journal of immunology (1950) (15-01-2001)“…Using a novel transgenic mouse model of spontaneous mammary carcinoma, we show here that the IL-12/pulse IL-2 combination can induce rapid and complete…”
Get full text
Journal Article -
3
Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2)
Published in The Journal of immunology (1950) (15-03-2001)“…The IFN-gamma-inducible proteins monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2) can contribute to IL-12-induced antiangiogenic…”
Get full text
Journal Article -
4
Flavone acetic acid directly induces expression of cytokine genes in mouse splenic leukocytes but not in human peripheral blood leukocytes
Published in Cancer research (Chicago, Ill.) (15-12-1991)“…Flavone-8-acetic acid (FAA) is a flavonoid drug that augments mouse natural killer activity, induces cytokine gene expression, and synergizes with recombinant…”
Get full text
Journal Article -
5
Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow
Published in The Journal of immunology (1950) (01-07-1989)“…A variety of biologic response modifiers (BRM) can potently augment NK activity in nonlymphoid organs. By using the liver as a model organ, we have shown that…”
Get full text
Journal Article -
6
Induction of transplantable mouse renal cell cancers by streptozotocin : In vivo growth, metastases, and angiogenic phenotype
Published in Cancer research (Chicago, Ill.) (15-08-2001)“…Interleukin-2-based regimens of biological therapy have shown some clinical promise for the treatment of kidney cancer in humans, although the mechanisms…”
Get full text
Journal Article -
7
Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases
Published in The Journal of immunology (1950) (15-06-1994)“…These studies investigate the effects of exogenously administered recombinant human IL-7 (rhIL-7) on mouse leukocyte subsets in vivo in normal and…”
Get full text
Journal Article -
8
Effects of rhIL-7 on leukocyte subsets in mice: implications for antitumor activity
Published in Immunology series (1994)Get more information
Journal Article -
9
In vivo distribution and cytokine gene expression by enriched mouse LAK effector cells
Published in Biotherapy (Dordrecht) (1991)“…Lymphokine activated killer (LAK) cells administered in combination with interleukin 2 (IL2) can mediate antitumor activity in tumor-bearing mice and advanced…”
Get full text
Journal Article -
10
Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1 : protection from hematological and nonhematological toxicities
Published in Cancer research (Chicago, Ill.) (01-08-1992)“…Previous studies have demonstrated that interleukin 1 (IL-1) can protect most mice from the acute lethal toxicity mediated by high doses of radiation and/or…”
Get full text
Journal Article